Birkenstock earnings top estimates after it raises prices

• These are the factors weighing on Block’s stock after earnings

  Block expects accelerating growth as the year goes on, but investors may have wanted more from the company’s overall gross-profit outlook.
  
  MarketWatch - 17h

• Alibaba shares soar nearly 15% after stellar earnings as China's e-commerce sector recovers

  Alibaba has been making 'significant strides' in advancing its AI cloud business after launching its Qwen 2.5-Max flagship AI foundation model, Barclays wrote in a note.
  
  CNBC - 10h

• Block shares plunge 17%, head for worst day in 5 years after earnings miss

  Block was on pace for its worst day on the stock market since 2020 after the company reported an earnings miss.
  
  CNBC - 28m
• 

  Birkenstock Loses Copyright Battle in German Court Ruling

  The famous sandal company lost a battle over copyright law, leaving room for imitations to spawn.
  
  The New York Times - 18h
• 

  Fluidstack in talks to raise $200m

  Yahoo News - 5h

• The Price You Pay: Egg prices’ impact on bakeries

  One of the downstream impacts of bird flu and the soaring egg prices: its impact on bakeries. We visit one Pittsburgh bakery struggling that’s seen egg prices soar in the last two years, and the ...
  
  NBC News - 18h
• 

  A Trump DOGE Dividend Could Raise Inflation

  President Trump floated giving taxpayers a piece of any savings that Elon Musk’s cost-cutting generates, which could reignite inflation.
  
  The New York Times - 1d
• 

  OpenInfer raises $8M for AI inference at the edge

  OpenInfer has raised $8 million in funding to redefine AI inference for edge applications. It’s the brain child of Behnam Bastani and Reza Nourai, who spent nearly a decade of building and scaling ...
  
  VentureBeat - 1d
• 

  Kendrick Lamar earns first UK number one with Not Like Us

  The diss track, the knockout blow in his feud with Drake, is now number one in both the US and UK.
  
  BBC News - 40m

• Musubi, AI content moderation startup, raises $5 million in seed funding

  Musubi, a startup that uses AI to moderate online content, raised $5 million in a seed round.
  
  CNBC - 5h

More from MarketWatch

• Nvidia options traders are vastly overestimating how earnings will move the stock. Just look at these charts.

  Nvidia options aren’t a good trade, this expert says. Here’s what he likes.
  
  MarketWatch - 6m

• Warren Buffett’s 2025 letter to Berkshire shareholders is coming tomorrow. Watch this number.

  Even Buffett is struggling to outperform this bull market. Berkshire’s massive cash stake is key.
  
  MarketWatch - 11m

• Board games and firepits: Senior communities are pulling out all the stops to lure Generation X. Here’s why.

  Retirement communities are courting members of Gen X, who will outnumber baby boomers in 2028.
  
  MarketWatch - 40m

• Treasury yields slip as data raise questions about strength of U.S. economy

  U.S. Treasury yields slipped on Friday after a fresh batch of data raised questions about the strength of the U.S. economy.
  
  MarketWatch - 1h

• Young traders don’t care if stocks and crypto are in a bubble. They could get a rude awakening.

  A new survey found that the majority of active traders are bullish, despite some thinking the market is in a bubble.
  
  MarketWatch - 1h

More in Business

• Nvidia options traders are vastly overestimating how earnings will move the stock. Just look at these charts.

  Nvidia options aren’t a good trade, this expert says. Here’s what he likes.
  
  MarketWatch - 6m

• Apple’s Vision Pro has a problem a year into its existence: Not enough apps

  Apple said in August that the Vision Pro had 2,500 apps. According to one firm's analysis, fewer than 1,900 remain active.
  
  CNBC - 10m

• Warren Buffett’s 2025 letter to Berkshire shareholders is coming tomorrow. Watch this number.

  Even Buffett is struggling to outperform this bull market. Berkshire’s massive cash stake is key.
  
  MarketWatch - 11m

• UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

  It extends a tumultuous period for UnitedHealth marked by the killing of a top executive, a costly cyberattack against its subsidiary and high medical costs.
  
  CNBC - 19m

• Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

  Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage
  
  CNBC - 27m